Literature DB >> 21917441

Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.

Cecilia García-Sancho1, Ivette Buendía-Roldán, Ma Rosario Fernández-Plata, Carmen Navarro, Rogelio Pérez-Padilla, Mario H Vargas, James E Loyd, Moisés Selman.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a lethal lung disorder of unknown etiology. The disease is likely the result of complex interactions between genetic and environmental factors. Evidence suggests that certain environmental factors, such as cigarette smoking and metal dust exposures, or comorbidities like gastroesophageal reflux, and type 2 diabetes mellitus (DM2) may increase risk to develop IPF. Substantial uncertainty remains, however, regarding these and other putative risk factors for IPF. In this study we performed a case-control analysis including 100 patients with IPF and 263 controls matched for age sex and place of residence. We used a structured questionnaire to identify potential risk factors for IPF, including environmental and occupational exposures as well as the relevance of family history of pulmonary fibrosis. The multivariate analysis revealed that family history of pulmonary fibrosis [OR = 6.1, CI95% 2.3-15.9; p < 0.0001] was strongly associated with increased risk of IPF. Actually, 20% of the cases reported a parent or sibling with pulmonary fibrosis. Gastroesophageal reflux [OR = 2.9, CI: 1.3-6.6; p = 0.007], former cigarette smoking [OR = 2.5, CI: 1.4-4.6, p = 0.003], and past or current occupational exposure to dusts, smokes, gases or chemicals [OR = 2.8, CI: 1.5-5.5; p = 0.002] were also associated with the disease. Despite being a significant risk factor on univariate analysis DM2 was not significant in multivariate analysis. These findings indicate that family history of pulmonary fibrosis is a strong risk factor for IPF. Also, we confirmed that occupational exposures, gastroesophageal reflux and former smoking increase the risk for this disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917441     DOI: 10.1016/j.rmed.2011.08.022

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  41 in total

1.  The genetic basis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; Timothy S Blackwell; James E Loyd
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

2.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-30       Impact factor: 84.694

Review 3.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

Review 4.  Plasma membrane wounding and repair in pulmonary diseases.

Authors:  Xiaofei Cong; Rolf D Hubmayr; Changgong Li; Xiaoli Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-06       Impact factor: 5.464

5.  A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia.

Authors:  Jonathan A Kropski; Daphne B Mitchell; Cheryl Markin; Vasiliy V Polosukhin; Leena Choi; Joyce E Johnson; William E Lawson; John A Phillips; Joy D Cogan; Timothy S Blackwell; James E Loyd
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

Review 6.  Genetic susceptibility and pulmonary fibrosis.

Authors:  Susan K Mathai; David A Schwartz; Laura A Warg
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

7.  Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.

Authors:  Gary M Hunninghake; Luisa D Quesada-Arias; Nikkola E Carmichael; Jose M Martinez Manzano; Sergio Poli De Frías; Maura Alvarez Baumgartner; Lisa DiGianni; Shannon N Gampala-Sagar; Dominick A Leone; Swati Gulati; Souheil El-Chemaly; Hilary J Goldberg; Rachel K Putman; Hiroto Hatabu; Benjamin A Raby; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

Review 8.  Familial Interstitial Lung Disease.

Authors:  Jonathan A Kropski
Journal:  Semin Respir Crit Care Med       Date:  2020-04-12       Impact factor: 3.119

Review 9.  Newly recognized occupational and environmental causes of chronic terminal airways and parenchymal lung disease.

Authors:  Maor Sauler; Mridu Gulati
Journal:  Clin Chest Med       Date:  2012-12       Impact factor: 2.878

Review 10.  Idiopathic pulmonary fibrosis: early detection and referral.

Authors:  Justin M Oldham; Imre Noth
Journal:  Respir Med       Date:  2014-04-04       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.